| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | tandutinib | CTRPv2 | pan-cancer | AAC | 0.0073 | 0.9 |
| mRNA | istradefylline | CTRPv2 | pan-cancer | AAC | 0.011 | 0.9 |
| mRNA | navitoclax:birinapant (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.007 | 0.9 |
| mRNA | foretinib | GDSC1000 | pan-cancer | AAC | -0.0063 | 0.9 |
| mRNA | Mitomycin-C | CTRPv2 | pan-cancer | AAC | 0.0064 | 0.9 |
| mRNA | SN-38 | CTRPv2 | pan-cancer | AAC | 0.007 | 0.9 |
| mRNA | BRD-K92856060 | CTRPv2 | pan-cancer | AAC | -0.0069 | 0.9 |
| mRNA | RG-108 | CTRPv2 | pan-cancer | AAC | -0.007 | 0.9 |
| mRNA | rTRAIL | GDSC1000 | pan-cancer | AAC | 0.0066 | 0.9 |
| mRNA | necrostatin-7 | CTRPv2 | pan-cancer | AAC | -0.0068 | 0.9 |